PGRI - ETF AI Analysis
Top Page
Putnam International Stock ETF (PGRI)
PGRI, the Putnam International Stock ETF, earns a solid overall rating mainly because several of its largest holdings—like Keyence, Hitachi, AstraZeneca, and ASML—show strong financial performance, good cash flow, and supportive business trends that help lift the fund’s quality. At the same time, holdings such as Airbus, Safran, and Compass face issues like bearish price momentum, high valuations, and profitability or cash flow challenges, which slightly weigh on the ETF’s rating. The main risk factor is the fund’s reliance on a concentrated set of international industrial and technology names, where valuation concerns and technical weakness could hurt returns if market conditions turn.
PGRI vs. SPDR S&P 500 ETF (SPY)
- AUM
- 6.47M
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.55%
- Beta
- 0.97
- Issuer
- Putnam
- Inception Date
- Oct 21, 2025
- Dividend Yield
- 0.12%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
PGRI Summary
PGRI, the Putnam International Stock ETF, is an actively managed fund that invests in large and mid-sized companies outside the U.S., across both developed and emerging markets, rather than tracking a fixed index. It focuses on a broad global theme, with big positions in well-known names like TSMC and ASML, and spreads money across technology, industrials, health care, and more. Someone might invest in PGRI to diversify beyond the U.S. and seek long-term growth from international markets. A key risk is that global stocks can be volatile and are affected by currency swings and overseas economic conditions.
How much will it cost me?
The Putnam International Stock ETF (PGRI) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?
The Putnam International Stock ETF (PGRI) could benefit from global economic growth and technological advancements, especially given its significant exposure to the technology sector and top holdings like TSMC and ASML. However, it may face challenges from geopolitical tensions, regulatory changes in emerging markets, or economic slowdowns in key regions outside the U.S. Additionally, fluctuations in currency exchange rates could impact returns due to its international focus.
PGRI Top 10 Holdings
PGRI leans heavily on a mix of industrial and tech champions, with Japan’s Hitachi and Keyence plus Europe’s ASML acting as key engines for the fund’s recent momentum. ASML and Keyence, both riding strong demand for advanced manufacturing and chips, have been rising and give the ETF a clear tilt toward high-end technology and automation. On the other side, Airbus and AstraZeneca are lagging, dulling some of that shine, while Shell’s steady energy gains help balance the picture. Overall, it’s a globally diversified, ex‑U.S. portfolio anchored in developed markets.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 GB:SHEL | Shell (UK) | 5.85% | $376.47K | GBP 229.30B | 40.01% | 73Outperform |
 JP:7741 | HOYA | 5.17% | $332.86K | JPY 8.76T | 8.19% | 74Outperform |
 JP:6501 | Hitachi,Ltd. | 4.82% | $310.52K | JPY 23.04T | 2.64% | 77Outperform |
 EADSF | Airbus Group SE | ― | ― | ― | ― | 68Neutral |
 KYCCF | Keyence | ― | ― | ― | ― | 81Outperform |
 FR:SAF | SAFRAN SA | 4.43% | $284.99K | EUR 114.94B | -9.72% | 67Neutral |
 GB:CPG | Compass | 4.29% | $276.19K | $57.32B | 1.10% | 64Neutral |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 NL:ASML | ASML Holding NV | 3.89% | $250.76K | EUR 539.67B | 50.70% | 76Outperform |
 SE:ABB | ABB Ltd | ― | ― | ― | ― | 78Outperform |
PGRI Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PGRI, the sentiment is Negative. The current price of 25.52 is below the 20-day moving average (MA) of 25.97, below the 50-day MA of 26.23, and below the 200-day MA of 26.23, indicating a bearish trend. The MACD of -0.15 indicates Positive momentum. The RSI at 38.68 is Neutral, neither overbought nor oversold. The STOCH value of 44.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PGRI.
PGRI Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PGRI | $25.52 | $28.00(9.72% Upside) | $6.47M | 0.55% | 70Outperform |
 GIEQ | $40.99 | $48.94(19.41% Upside) | $61.89M | 0.30% | 66Neutral |
 PJIO | $57.60 | $79.20(37.50% Upside) | $59.07M | 0.54% | 64Neutral |
 AADR | $80.02 | $93.98(17.45% Upside) | $35.14M | 1.09% | 69Neutral |
 ABLG | $28.31 | ― | $13.06M | 0.54% | 61Neutral |
 VNIE | $24.46 | $28.94(18.35% Upside) | $8.65M | 0.60% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PGRI | Putnam International Stock ETF | 25.52 | 0.59 | 2.35% | |
| GIEQ | Goldman Sachs Data Enhanced International Equity ETF | 40.98 | 0.49 | 1.21% | |
| PJIO | PGIM Jennison International Opportunities ETF | 57.60 | -6.29 | -9.84% | |
| AADR | AdvisorShares Dorsey Wright ADR ETF | 80.02 | -3.52 | -4.22% | |
| ABLG | Abacus Fcf International Leaders Etf | 28.31 | -2.44 | -7.93% | |
| VNIE | Vontobel International Equity Active ETF | 24.45 | -0.38 | -1.51% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.